1,842
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Explaining a possible protective role of polymorphous light eruption against skin cancer

&
Pages 309-311 | Published online: 10 Jan 2014

References

  • de Gruijl FR, van Kranen HJ, Mullenders LH. UV-induced DNA damage, repair, mutations and oncogenic pathways in skin cancer. J. Photochem. Photobiol. B63(1–3), 19–27 (2001).
  • Kripke ML. Antigenicity of murine skin tumors induced by ultraviolet light. J. Natl Cancer Inst.53(5), 1333–1336 (1974).
  • Schwarz T. 25 years of UV-induced immunosuppression mediated by T cells – from disregarded T suppressor cells to highly respected regulatory T cells. Photochem. Photobiol.84(1), 10–18 (2008).
  • Miyauchi-Hashimoto H, Tanaka K, Horio T. Enhanced inflammation and immunosuppression by ultraviolet radiation in xeroderma pigmentosum group A (XPA) model mice. J. Invest. Dermatol.107(3), 343–348 (1996).
  • Norval M. The mechanisms and consequences of ultraviolet-induced immunosuppression. Prog. Biophys. Mol. Biol.92(1), 108–118 (2006).
  • Yoshikawa T, Rae V, Bruins-Slot W, Van den Berg JW, Taylor JR, Streilein JW. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J. Invest. Dermatol.95(5), 530–536 (1990).
  • Sleijffers A, Garssen J, Van Loveren H. Ultraviolet radiation, resistance to infectious diseases, and vaccination responses. Methods28(1), 111–121 (2002).
  • Cooper KD, Oberhelman L, Hamilton TA et al. UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc. Natl Acad. Sci. USA89(18), 8497–8501 (1992).
  • Kelly DA, Young AR, McGregor JM, Seed PT, Potten CS, Walker SL. Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J. Exp. Med.191(3), 561–566 (2000).
  • Bennett MF, Robinson MK, Baron ED, Cooper KD. Skin immune systems and inflammation: protector of the skin or promoter of aging? J. Investig. Dermatol. Symp. Proc.13(1), 15–19 (2008).
  • Rhodes LE, Bock M, Janssens AS et al. Polymorphic light eruption occurs in 18% Europeans and does not exhibit higher prevalence with increasing latitude. Multicentre survey in 6895 individuals residing from the Mediterranean to Scandinavia. J. Invest. Dermatol. (In press).
  • Kölgen W, Van Weelden H, Den Hengst S et al. CD11b+ cells and ultraviolet-B-resistant CD1a+ cells in skin of patients with polymorphous light eruption. J. Invest. Dermatol.113(1), 4–10 (1999).
  • Kölgen W, van Meurs M, Jongsma M et al. Differential expression of cytokines in UV-B-exposed skin of patients with polymorphous light eruption: correlation with Langerhans cell migration and immunosuppression. Arch. Dermatol.140(3), 295–302 (2004).
  • Janssens AS, Pavel S, Tensen CP et al. Reduced IL-1Ra/IL-1 ratio in ultraviolet B-exposed skin of patients with polymorphic light eruption. Exp. Dermatol.18(3), 212–217 (2009).
  • van de Pas CB, Kelly DA, Seed PT, Young AR, Hawk JL, Walker SL. Ultraviolet-radiation-induced erythema and suppression of contact hypersensitivity responses in patients with polymorphic light eruption. J. Invest. Dermatol.122(2), 295–299 (2004).
  • Palmer RA, Friedmann PS. Ultraviolet radiation causes less immunosuppression in patients with polymorphic light eruption than in controls. J. Invest. Dermatol.122(2), 291–294 (2004).
  • Lembo S, Fallon J, O’Kelly P, Murphy GM. Polymorphic light eruption and skin cancer prevalence: is one protective against the other? Br. J. Dermatol.159(6), 1342–1347 (2008).
  • Benanni B, Bruckner T, Bock M et al. Low incidence of polymorphous light eruption in renal transplant recipients. Acta Derm. Venereol.87, 372–374 (2007).
  • Ling TC, Gibbs NK, Rhodes LE. Treatment of polymorphic light eruption. Photodermatol. Photoimmunol. Photomed.19(5), 217–227 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.